Abstract
Introduction and aim
Neuropsychiatric complications that develop after living donor liver transplantation (LT) are frequently encountered, though not adequately estimated among Egyptian recipients. We aimed to estimate the frequency of neuropsychiatric manifestations and neurocognitive functional changes after living donor LT.
Patients and methods
A prospective observational cohort study was conducted to evaluate 30 adult patients with end-stage liver disease preoperatively in a single Egyptian Transplant Center from November 2012 till January 2014. Relevant preoperative, intraoperative, and postoperative data were recorded and recollected and at 3 and 6 months of follow-up. The assessment included neurologic evaluation, Child–Turcotte–Pugh score, model of end-stage liver disease score, clinical hepatic encephalopathy staging scale, West Haven criteria, and International Society for Hepatic Encephalopathy and Nitrogen Metabolism score for semiquantitative assessment of encephalopathy.
Results
Hepatitis C virus was the main etiology for liver disease in 27 (90%) patients. Overt hepatic encephalopathy was seen in 26.6%, whereas covert hepatic encephalopathy occurred in 43.3%. Postoperatively, 76.7% of the patients demonstrated neuropsychiatric manifestations, with 50% of them showing mainly early major events, namely, encephalopathy. Late minor manifestation rates were 50%. Early cyclosporine administration and cold ischemia time longer than 40 min were significant predictors of occurrence of early neurologic events postoperatively (P=0.031 and 0.025, respectively). Both risk factors were associated with earlier and higher rates of neurologic complications.
Conclusion
Patients of living donor LT are at increased risk of developing early postoperative major neurologic sequelae, which become of less clinical significance later on. The patients’ cognitive functions improve with time after transplant.
Article PDF
Similar content being viewed by others
References
Saner FH, Gensicke J, Olde Damink SWM, Pavlaković G, Treckmann J, Dammann M, et al. Neurologic complications in adult living donor liver transplant patients: an underestimated factor?. J Neurol J Neurol 2010; 257:253–258.
Starzl TE, Iwatsuki S, Esquivel CO, Todo S, Kam I, Lynch S, et al. Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985; 5:349–356.
Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology 2003; 61:1174–1178.
Guarino M. Immunosuppressive therapy. Gastroenterol Int Congress Proc 1999; 12:140–145.
Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care 2008; 8:253–258.
Zivković SA. Neurologic complications after liver transplantation. World J Hepatol 2013; 5:409–416.
Teperman LW. Impact of pretransplant hepatic encephalopathy on liver post-transplantation outcomes. Int J Hepatol 2013; 2013:952828.
Wang WL, Yang ZF, Lo CM, Liu CL, Fan ST. Intracerebral hemorrhage after liver transplantation. Liver Transpl 2000; 6:345–348.
Murray KF, Carithers RL. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41:1407–1432.
Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by AASLD and EASL. Hepatology 2014; 60:715–735.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2:81–84.
Ardizzone G, Arrigo A, Schellino MM, Stratta C, Valzan S, Skurzak S, et al. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc 2006; 38:789–792.
Amodio P, Biancardi A, Montagnese S, Angeli P, Iannizzi P, Cillo U, et al. Neurological complications after orthotopic liver transplantation. Dig Liver Dis 2007; 39:740–747.
El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009.
Ministry of Health and Population (Egypt), El-Zanaty and Associates (Egypt) and and ICF International. Egypt Health Issues Survey 2015. Cairo, Egypt and Rockville, Maryland, USA: Ministry of Health and Population and ICF International; 2015.
Vizzini G, Asaro M, Miraglia R, Gruttadauria S, Filì D, D’Antoni A, et al. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl 2011; 17:1279–1285.
Kim BS, Lee SG, Hwang S, Park KM, Kim KH, Ahn CS, et al. Neurologic complications in adult living donor liver transplant recipients. Clin Transplant 2007; 21:544–547.
Ghaus N, Bohlega S, Rezeig M. Neurological complications in liver transplantation. J Neurol 2001; 248:1042–1048.
Amin ME, Atta FE. Neuropsychiatric complications after liver transplantation. Egypt J Psychiatr 2012; 33:57–62.
Saner F, Gu Y, Minouchehr S, Ilker K, Fruhauf NR, Paul A, et al. Neurological complications after cadaveric and living donor liver transplantation. J Neurol 2006; 253:612–617.
Pujol A, Graus F, Rimola A, Beltrán J, Garcia-Valdecasas JC, Navasa M, et al. Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994; 44:1226–1230.
Ferreiro JA, Robert MA, Townsend J, Vinters HV. Neuropathologic findings after liver transplantation. Acta Neuropathologica 1992; 84:1–14.
Anghel D, Tanasescu R, Campeanu A, Lupescu I, Podda G, Bajenaru O. Neurotoxicity of Immunosuppressive Therapies in Organ Transplantation. Maedica (Buchar) 2013; 8:170–175.
Campagna F, Biancardi A, Cillo U, Gatta A, Amodio P. Neurocognitive-neurological complications of liver transplantation: a review. Metab Brain Dis 2010; 25:115–124.
Balderramo D, Prieto J, Cárdenas A, Navasa M. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation. Transpl Int 2011; 24:812–819.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sakr, M.A., El-Naggar, M.K., Khalifa, M.O. et al. Neuropsychiatric complications after living donor liver transplantation: a prospective case series in an Egyptian center. Egypt J Intern Med 30, 239–248 (2018). https://doi.org/10.4103/ejim.ejim_41_18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_41_18